Issue navigation
Volume 23, Issue 11, 1 November 2017
Clinical Review Article
Large Registry Epidemiology in IBD
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1941–1949, https://doi.org/10.1097/MIB.0000000000001279
Commentary
PUFAs and IBD: Is There a Relationship?
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1905–1907, https://doi.org/10.1097/MIB.0000000000001253
Erratum
IBD LIVE Series—Case 8: Treatment Options for Refractory Esophageal Crohn’s Disease and Hidradenitis Suppurativa: ERRATUM
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Page E56, https://doi.org/10.1097/MIB.0000000000001293
Future Directions and Methods for IBD Research
The Association Between Drug Levels and Endoscopic Recurrence in Postoperative Patients with Crohn's Disease Treated with Tumor Necrosis Factor Inhibitors
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1924–1929, https://doi.org/10.1097/MIB.0000000000001220
Cost–utility Analysis: Thiopurines Plus Endoscopy-guided Biological Step-up Therapy is the Optimal Management of Postoperative Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1930–1940, https://doi.org/10.1097/MIB.0000000000001233
IBD LIVE
Predictors of Early Readmission in Hospitalized Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1891–1897, https://doi.org/10.1097/MIB.0000000000001213
Anti–TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate–severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1916–1923, https://doi.org/10.1097/MIB.0000000000001234
Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1898–1904, https://doi.org/10.1097/MIB.0000000000001236
Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1908–1915, https://doi.org/10.1097/MIB.0000000000001237
Letters to the Editor
Inflammatory Bowel Disease, the Hospital Anxiety and Depression Scale and Criterion Contamination
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Page E54, https://doi.org/10.1097/MIB.0000000000001278
How to Avoid Primary Nonresponders to Infliximab in Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages E55–E56, https://doi.org/10.1097/MIB.0000000000001281
Reply
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages E54–E55, https://doi.org/10.1097/MIB.0000000000001284
Original Article
Inflammatory Bowel Diseases in Children and Young Adults with Celiac Disease. A Multigroup Matched Comparison
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1996–2000, https://doi.org/10.1097/MIB.0000000000001098
Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2011–2017, https://doi.org/10.1097/MIB.0000000000001168
A Simple Ultrasound Score for the Accurate Detection of Inflammatory Activity in Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2001–2010, https://doi.org/10.1097/MIB.0000000000001174
Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2018–2026, https://doi.org/10.1097/MIB.0000000000001191
Fecal Calprotectin More Accurately Predicts Endoscopic Remission of Crohn's Disease than Serological Biomarkers Evaluated Using Balloon-assisted Enteroscopy
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2027–2034, https://doi.org/10.1097/MIB.0000000000001202
Clinical Predictors and Natural History of Disease Extension in Patients with Ulcerative Proctitis
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2035–2041, https://doi.org/10.1097/MIB.0000000000001214
Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2054–2060, https://doi.org/10.1097/MIB.0000000000001221
Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2048–2053, https://doi.org/10.1097/MIB.0000000000001223
Incidence and Outcomes of Central Venous Catheter–related Blood Stream Infection in Patients with Inflammatory Bowel Disease in Routine Clinical Practice Setting
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2042–2047, https://doi.org/10.1097/MIB.0000000000001230
Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 2061–2068, https://doi.org/10.1097/MIB.0000000000001240
Comparison of Stromal Vascular Fraction with or Without a Novel Bioscaffold to Fibrin Glue in a Porcine Model of Mechanically Induced Anorectal Fistula
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1962–1971, https://doi.org/10.1097/MIB.0000000000001254
Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1950–1961, https://doi.org/10.1097/MIB.0000000000001270
Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1972–1982, https://doi.org/10.1097/MIB.0000000000001273
Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10–Dependent, T-Cell–Independent Attenuation of Colonic Mucosal Innate Immune Responses
Inflammatory Bowel Diseases, Volume 23, Issue 11, 1 November 2017, Pages 1983–1995, https://doi.org/10.1097/MIB.0000000000001274
